Apogee Therapeutics, Inc. (APGE) Operating cash flow 2023–2025
Apogee Therapeutics, Inc. (APGE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$227.4MFY2025 · since FY2023: -$74.8M → -$227.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$227.4M | -32.9% |
| FY2024 | -$171.2M | -129.0% |
| FY2023 | -$74.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice